Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users

Inclusion Criteria

• •Participating individuals must:
• •1. be at least 18 years old
• •2. be HIV-seropositive (confirmed via medical record/laboratory results or via rapid HIV test in conjunction with confirmatory test or viral load)
• •3. meet one of the following: a) have an (\*)AIDS-defining illness OR b) have a CD4 count \<350 cells/uL AND a viral load \>1000 copies/mL in the medical record in the past 3 months OR c) have a CD4 count \<350 cells/uL AND a viral load \>200 copies/mL as obtained via baseline blood draw OR d) have a clinical profile indicative of a persistently detectable HIV viral load (\>200 copies/mL) attributed to non-adherence to HIV medications as per PI evaluation of the individual and/or individual's medical record
• •4. report (OR have evidence in the medical record of) any cocaine (including crack) use in the past 3 months OR (\*\*)have a positive toxicology result for cocaine via the study toxicology screen
• •5. agree to have their blood drawn for CD4 and viral load testing
• •6. report living in or near either Miami, Florida (FL), or Atlanta, Georgia (GA), and be able to return for follow-up visits
• •7. provide locator information
• •8. be able to communicate in English
• •9. provide written informed consent
• •10. sign a HIPAA Authorization form/medical record release to facilitate medical record abstraction
• •11. be willing to go to the study clinic
• •(\*)Site PI discretion will be used to assess whether or not the AIDS-defining illness is a good indicator of eligibility. For example, if a patient does not meet the CD4 and viral load criteria and does have an AIDS-defining illness, the Site PI will assess the AIDS-defining illness to determine whether or not the patient is a suitable candidate for the study.
• •(\*\*)Per PI discretion, the urine toxicology screen may be administered as part of the screening process if the participant's self-report and/or medical record data renders him/her ineligible on the drug use criterion.
• •2. are receiving patient navigator services for HIV care and/or substance abuse treatment
• •3. have significant cognitive or developmental impairment to the extent that they are unable to provide informed consent
• •4. are terminated via site PI decision